A Study to Assess False Positive HIV-2 Testing

Overview

About this study

  1. To describe the demographics and comorbidities of patients with false positive testing for HIV-1 and HIV 2 (defined as positive or indeterminate antibody screening which failed to be confirmed by polymerase chain reaction testing).
  2. To review occupational exposures documented on these patients, particularly working in meat processing facilities, based on a prior reported association

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Individuals ≥ 18 years of age.
  • False positive HIV 2 test with a positive or indeterminate HIV2 antibody test and negative PCR testing.
  • Must have been seen in the Mayo Clinic Infectious Disease/HIV Clinic

Exclusion Criteria:

  • Individuals < 18 years of age.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Mary Kasten, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions